Figure 6.

Accelerated wound healing by local activation of the Wnt signaling pathway. A: Subconjunctival injection of a Wnt signaling activator Ad-S37A (10 µL of 1 × 10⁷ inclusion-forming units/mL per eye) enhanced corneal wound closure in WT mice, relative to the control injected with the same titer of Ad-β-gal (n = 10). B: WT mice receiving LiCl (10 μL of 0.9% per eye) subconjunctival injection with NaCl for control (n = 10). C: KS-Tg mice receiving LiCl (10 μL of 0.9% per eye) subconjunctival injection with NaCl as control (n = 10). All values are mean ± SEM. *P < 0.05; **P < 0.01; ***P < 0.001.